Dig­i­tal health start­up Ro now pre­scribes re­cent­ly ap­proved weight loss drug Zep­bound

A dig­i­tal health start­up is jump­ing in to of­fer the lat­est weight loss drug ap­proved by the FDA.

Ro, a start­up that pre­scribes and ships med­ica­tion di­rect­ly to cus­tomers, is adding tirzepatide to its list of weight loss med­ica­tion of­fer­ings, the com­pa­ny an­nounced on Wednes­day. The Eli Lil­ly drug was ap­proved for weight man­age­ment last month with the mar­ket­ing name Zep­bound.

“Zep­bound is poised to be the most im­pact­ful an­ti-obe­si­ty med­ica­tion we’ve seen so far in our life­time,” Ro’s chief med­ical of­fi­cer Dr. Melyn­da Barnes said in a state­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER